What we know
Summary Date Recall was issued:Product Name:Manufacturer:Recalling Firm:Batch(es):Manufacturing Date:Expiry Date:Reason for Recall: 25th February 2020Albendazole tablets 400mgGlaxoSmithKlineGlaxoSmithKline35013708-201508-2020 Substandard (Product failed quality evaluation with respect to Dissolution) AnnouncementThis recall is necessitated as a result of warehouse market surveillance conducted at the warehouse. Actual product specification is a powder for oral suspension. The affected batches were caked and not free flowing. This makes the product substandard and therefore not recommended for its intended use.
Safety advice
- Stop using or purchasing the product if the notice asks you to.
- Keep receipts, batch numbers and packaging — they help with returns or investigations.
- Share this alert with anyone who might be affected, especially relatives and colleagues.
- If you believe you’ve been harmed, contact the official source or a relevant authority.